AstraZeneca plc vs Alibaba Group — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Alibaba Group trades at $125.7 (market cap $308.93B). The key difference: Alibaba Group is the larger of the two by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | BABA | |
|---|---|---|
Market Cap | $248.14B | $308.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $189.34 |
52-Week Low | $147.06 | $94.83 |
Enterprise Value | $275.41B | $303.72B |
Dividend Yield | 2.01% | 0.82% |
Volume | — | 18,069,938 |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →